SPENCER HAMNER: Open Payments
NPI 1598853715 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 36 payments from 10 companies in 2025. Trend: 2023 $1,090 · 2024 $849 · 2025 $846
Food & beverage: $546Education: $300
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $276 |
| ABBVIE INC. | 10 | $172 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $160 |
| UCB, Inc. | 6 | $114 |
| Incyte Corporation | 2 | $37 |
| Lilly USA, LLC | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| GENZYME CORPORATION | 1 | $16 |
| Galderma Laboratories, L.P. | 1 | $16 |
| Organon LLC | 3 | $13 |
Products named: TREMFYA, Bimzelx, BOTOX, RINVOQ, ILUMYA, OPZELURA, DUPIXENT, TALTZ.
Industry payments across NE — which companies pay providers there.
